Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
US6759432B2 · kind B2 · utility
1Cited by
7References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 29, 2002 |
| Grant date | Jul 6, 2004 |
| Priority date | — |
| Expiry date | Sep 6, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/782
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of an MMP inhibitor, especially a collagenase inhibitor, in the manufacture of a medicament for the treatment of a natural or artificial tissue comprising extracellular matrix components to inhibit contraction of the tissue and methods for the treatment of tissue comprising extracellular matrix components to inhibit contraction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.